$A high TP53 mutation burden is a strong predictor of primary refractory mantle cell lymphoma$

A high TP53 mutation burden is a strong predictor of primary refractory mantle cell lymphoma

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of haematology 2020-12, Vol.191 (5), p.e103-e106
Hauptverfasser:	Obr, Ales, Klener, Pavel, Furst, Tomas, Kriegova, Eva, Zemanova, Zuzana, Urbankova, Helena, Jirkuvova, Andrea, Petrackova, Anna, Malarikova, Diana, Forsterova, Kristina, Cudova, Barbora, Sedlarikova, Lenka, Berkova, Adela, Kasalova, Nela, Papajik, Tomas, Trneny, Marek
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Antineoplastic Combined Chemotherapy Protocols - administration & dosage chemoresistance Cyclophosphamide - administration & dosage Disease-Free Survival Doxorubicin - administration & dosage Female Hematology Humans Lymphoma, Mantle-Cell - drug therapy Lymphoma, Mantle-Cell - genetics Lymphoma, Mantle-Cell - mortality Male Mantle cell lymphoma Middle Aged Mutation mutation burden p53 Protein Prednisone - administration & dosage Retrospective Studies Survival Rate TP53 aberration Tumor Suppressor Protein p53 - genetics Vincristine - administration & dosage
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!